Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Chilling the brain: scientists probe Temperature's role in brain plasticity

NCT ID NCT02363296

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 5 times

Summary

This study looked at how cooling the brain changes its activity in healthy adults. Participants wore a cooling cap while researchers measured brain responses using transcranial magnetic stimulation (TMS). The goal was to better understand brain plasticity, not to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

44 people

The number who actually took part.

Started

May 2016

Finished

Aug 2025

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: Main Study: To be eligible for this research study participants must: * Be between 18 and 50 years of age. * Be right-handed. * Able to abstain from food or drinks containing caffeine 24 hours before the last 3 session visits. The screening visit does not require the ability to abstain from food or drinks containing caffeine. * Able to abstain from tobacco on the day of the last three session visits. The screening visit doesn t require the ability to abstain from tobacco. Sub-study: Phase-triggered paired associative stimulation (PAS) * Males and females between 18 and 35 years of age. * Subjects must be able to give written informed consent prior to participation in this study. EXCLUSION CRITERIA: Main Study: Participants will be excluded from this research study if they: * Are taking medications of the following classes: antidepressants, anxiolytics, anticonvulsants, antipsychotics, antiparkinson, hypnotics, stimulants, and antihistamines. * Have a heart rate that exceeds 100 bpm (resting tachycardia). * Have a history of psychiatric condition(s). * Have a neurologic disorder such as a history of brain tumor, stroke, central nervous system infection, epilepsy, cerebrovascular disease, dementia, head trauma, or increased intracranial pressure. * Have surgically or traumatically implanted metallic foreign bodies such as, pacemakers, medication pumps, implanted hearing aids, defibrillators, metal plates in the skull or metal implants in the skull or eyes (other than dental fillings), intracardiac lines, or any other condition/device that might be physically hazardous during TMS or magnetic resonance imaging (MRI), or might distort the images. * Are unable to lie flat on back for up to 1 hour. * Have claustrophobia or a feeling of discomfort from being in small, enclosed spaces of enough severity to prevent MRI scanning. * Are pregnant or have a positive pregnancy test before the research procedure due to the risks associated with MRI scans and TMS. * Have abnormal findings in clinical MRI that we will do during the screening visit. * Have any abnormal or focal finding on the neurological exam. * Have a known hearing loss. * Have an alcohol or substance abuse problem, as determined by the Alcohol, Smoking and Substance Abuse Screening Test (ASSIST). * Have sensitivity to coldness. (main experiment only, not an exclusion for the sub-study which does not utilize cooling) * NIMH employees and staff and their immediate family members will be excluded from the study per NIMH policy. Sub-study: Phase-triggered paired associative stimulation (PAS) * Individuals taking medication that, in the opinion of the investigator, significantly lowers seizure threshold. * Have a history of psychiatric condition(s). * Have a neurologic disorder such as a history of brain tumor, stroke, central nervous system infection, epilepsy, cerebrovascular disease, dementia, head trauma, or increased intracranial pressure. * Have abnormal findings in MRI that will be conducted during screening or prior to TMS under the current protocol * Are pregnant or have a positive pregnancy test before the beginning of the study due to the risks associated with TMS. * Subjects who have hearing loss that has been clinically evaluated and diagnosed. * Any implant, prosthesis or other permanent alteration of the body that, in the opinion of the investigator, would be unsafe with TMS or that would produce an artifact that would compromise the integrity of data. * Positive test for HIV. * Have an alcohol or substance abuse problem. * NIMH employees and staff and their immediate family members will be excluded from the study per NIMH policy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.